Page 3 - Genomic Sciences News Today

Eliminating certain factors within the GRN resulted in the network shutting down, potentially leading to cancer cell death due to an inability to replicate, according to the study authors.

Statistical technique enhances genetic disease prediction in non-European populations, addressing healthcare equity. A team of scientists from Icahn School of Medicine at Mount Sinai has developed a groundbreaking statistical technique, “BridgePRS,” to enhance disease prediction in people of non-

Groundbreaking study opens new avenues for future treatment and diagnosis.

The Department of Immunology and Immunotherapy and the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai have been awarded a $5 million grant from the National Cancer Institute of the National Institutes of Health to establish a state-of-the-art center dedicated to the discovery and development of cutting-edge targets for cancer therapy.

Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School of Medicine at Mount Sinai and colleagues have identified a 64-protein signature that may predict a subset of ovarian cancer patients who are unlikely to respond to chemotherapy.

New York NY (SPX) Nov 16, 2023 - Mount Sinais Cardiovascular Research Institute is sending bioengineered human heart muscle cells and micro-tissues into space for the first time on NASAs 29th SpaceX commercial resupply services m

Findings will help scientists understand how microgravity impacts the ability of human heart cells to withstand the stresses of space travel

Researchers at the Mount Sinai Center for Transformative Disease Modeling have released a groundbreaking study identifying 4,749 key gene clusters, termed "prognostic modules," that significantly influence the progression of 32 different types of cancer.

A doctor on social media controversially said that oral sex is the number one cause of throat cancer and while many doubt her, others in the medical field have made the same claim. 

Tenure-track faculty positions RNA/CRISPR Therapeutics, Gene & Cell Therapy, Nanoparticle Medicine job in New York City, New York (US) with ICAHN GENOMICS INSTITUTE. Apply Today.